Sanofi - Common Stock and American Depositary Receipts (SNY) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock and American Depositary Receipts
Symbol
SNY on Nasdaq
Shares outstanding
1,227,820,098
Price per share
$46.18
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
222,580,825
Total reported value
$10,786,656,216
% of total 13F portfolios
0.01%
Share change
-14,138,258
Value change
-$681,048,358
Number of holders
728
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sanofi - Common Stock and American Depositary Receipts (SNY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Amundi 5.1% -2% $3,034,811,531 -$55,981,648 62,741,607 -1.8% AMUNDI 31 Dec 2025

As of 31 Dec 2025, 728 institutional investors reported holding 222,580,825 shares of Sanofi - Common Stock and American Depositary Receipts (SNY). This represents 18% of the company’s total 1,227,820,098 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Sanofi - Common Stock and American Depositary Receipts (SNY) together control 13% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dodge & Cox 4.6% 56,492,599 -18% 1.5% $2,737,631,348
Fisher Asset Management, LLC 0.99% 12,140,615 -3.5% 0.2% $588,334,216
MORGAN STANLEY 0.74% 9,102,196 +20% 0.03% $441,092,545
BANK OF AMERICA CORP /DE/ 0.7% 8,544,008 -13% 0.03% $414,042,636
BARROW HANLEY MEWHINNEY & STRAUSS LLC 0.57% 6,968,413 -2.2% 1.1% $337,689,294
Invesco Ltd. 0.5% 6,110,874 +5.4% 0.05% $296,132,935
BlackRock, Inc. 0.44% 5,345,618 -4.2% 0% $259,048,642
FRANKLIN RESOURCES INC 0.42% 5,100,097 +30% 0.06% $247,150,712
Mondrian Investment Partners LTD 0.37% 4,495,348 +24% 3.6% $217,844,540
FEDERATED HERMES, INC. 0.3% 3,642,307 +20% 0.29% $176,506,195
Boston Partners 0.3% 3,634,525 -1.2% 0.18% $176,070,647
FMR LLC 0.28% 3,400,192 +14% 0.01% $164,773,316
RAYMOND JAMES FINANCIAL INC 0.27% 3,292,546 -4.2% 0.05% $159,559,815
NATIXIS ADVISORS, LLC 0.26% 3,234,911 +3.9% 0.22% $156,764,000
ENVESTNET ASSET MANAGEMENT INC 0.26% 3,188,607 -6.4% 0.05% $154,519,885
JPMORGAN CHASE & CO 0.25% 3,010,958 +13% 0.01% $145,911,078
WELLINGTON MANAGEMENT GROUP LLP 0.24% 2,928,047 -29% 0.02% $141,893,158
BRANDES INVESTMENT PARTNERS, LP 0.24% 2,913,256 +3.2% 1.1% $141,177,295
PRICE T ROWE ASSOCIATES INC /MD/ 0.23% 2,873,659 -51% 0.02% $139,259,000
WELLS FARGO & COMPANY/MN 0.22% 2,741,743 -4.9% 0.03% $132,864,875
ROYAL BANK OF CANADA 0.22% 2,684,198 -18% 0.02% $130,076,000
EQUITY INVESTMENT CORP 0.21% 2,624,212 +1.4% 2.6% $127,169,335
NORTHERN TRUST CORP 0.18% 2,225,679 +2.8% 0.01% $107,856,404
AMERICAN CENTURY COMPANIES INC 0.17% 2,138,154 -8.6% 0.05% $103,614,943
BARCLAYS PLC 0.17% 2,134,056 +29% 0.04% $103,416,352

Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 222,580,825 $10,786,656,216 -$681,048,358 $48.46 728
2025 Q3 237,677,230 $11,218,512,587 -$539,879,761 $47.20 701
2025 Q2 244,532,481 $11,812,873,118 -$577,758,150 $48.31 717
2025 Q1 259,741,454 $14,403,933,993 -$180,220,976 $55.46 757
2024 Q4 264,228,568 $12,767,462,065 -$860,043,070 $48.23 720
2024 Q3 281,437,276 $16,222,731,951 +$599,910,816 $57.63 744
2024 Q2 271,128,567 $13,168,013,404 +$734,828,511 $48.52 712
2024 Q1 256,520,993 $12,465,528,859 +$459,383,443 $48.60 698
2023 Q4 247,194,308 $12,294,763,036 -$268,613,679 $49.73 698
2023 Q3 251,752,026 $13,498,268,433 -$168,648,433 $53.64 687
2023 Q2 254,140,019 $13,695,080,217 -$662,761,362 $53.90 664
2023 Q1 263,991,705 $14,365,235,158 +$295,714,571 $54.42 662
2022 Q4 261,245,630 $12,652,591,879 +$345,396,940 $48.43 630
2022 Q3 254,419,132 $9,679,406,899 -$220,838,009 $38.02 562
2022 Q2 258,121,644 $12,915,929,131 +$532,423,962 $50.03 637
2022 Q1 251,526,218 $12,914,867,229 +$355,652,280 $51.34 610
2021 Q4 244,191,155 $12,234,368,681 +$342,381,878 $50.10 612
2021 Q3 236,248,213 $11,390,183,250 +$1,641,499,675 $48.21 572
2021 Q2 202,238,449 $10,649,575,635 +$297,631,632 $52.66 579
2021 Q1 196,660,583 $9,730,710,157 +$1,139,121,574 $49.46 565
2020 Q4 174,769,250 $8,491,830,029 +$61,794,877 $48.59 595
2020 Q3 173,172,484 $8,683,724,393 -$298,357,223 $50.17 566
2020 Q2 179,099,760 $9,144,094,351 -$395,321,354 $51.05 575
2020 Q1 186,717,895 $8,166,009,933 +$342,858,039 $43.72 539
2019 Q4 179,412,304 $9,007,018,016 +$33,540,485 $50.20 522
2019 Q3 178,747,190 $8,281,847,601 +$157,742,639 $46.33 478
2019 Q2 175,287,706 $7,583,018,354 -$253,174,871 $43.27 475
2019 Q1 181,359,802 $8,033,461,634 +$105,149,552 $44.28 486
2018 Q4 179,020,645 $7,771,235,545 +$83,020,134 $43.41 498
2018 Q3 176,735,483 $7,894,668,701 -$512,133,501 $44.67 475
2018 Q2 188,812,117 $7,555,423,169 -$944,260,675 $40.01 471
2018 Q1 212,665,163 $8,522,811,095 -$560,500,136 $40.08 481
2017 Q4 225,668,043 $9,705,403,609 -$178,374,189 $43.00 499
2017 Q3 229,097,458 $11,406,131,330 -$296,834,002 $49.79 481
2017 Q2 235,283,446 $11,272,196,004 -$671,740,283 $47.91 472
2017 Q1 249,900,242 $11,309,226,808 +$51,244,579 $45.25 454
2016 Q4 250,487,680 $10,128,885,238 -$99,263,123 $40.44 474
2016 Q3 252,687,690 $9,649,929,933 +$379,085,646 $38.19 444
2016 Q2 242,485,985 $10,141,822,135 +$485,955,194 $41.85 443
2016 Q1 230,853,781 $9,324,847,553 +$92,618,017 $40.16 441
2015 Q4 228,264,346 $9,734,651,181 -$541,154,750 $42.65 474
2015 Q3 241,034,729 $11,441,945,895 -$462,167,076 $47.47 489
2015 Q2 252,781,737 $12,513,925,420 -$259,596,471 $49.53 494
2015 Q1 256,853,305 $12,698,339,817 +$435,090,390 $49.44 509
2014 Q4 249,735,459 $11,391,264,286 +$343,354,080 $45.61 492
2014 Q3 240,905,684 $13,595,205,282 +$165,715,991 $56.43 497
2014 Q2 238,031,863 $12,655,237,095 +$118,963,275 $53.17 484
2014 Q1 236,139,921 $12,345,371,497 +$580,061,154 $52.28 485